newsfilter
← Latest News
PR Newswire·

Seelos Therapeutics Provides Clinical Update and Reports First Quarter 2023 Financial Results

- Seelos expects to release top-line data in two registrational studies in 2023 NEW YORK, May 15, 2023 /PRNewswire/ -- Seelos Therapeutics, Inc. (NASDAQ:SEEL) ("Seelos"), a clinical-stage biopharmaceutical